NEW YORK, Oct. 4, 2019 — LMG Life Sciences has recognized King & Spalding with multiple rankings in the 2019 edition of its guide, which identifies the leading law firms and lawyers serving the life sciences industry.
The firm ranks as “highly recommended” in three categories:
- U.S. Food & Drug Administration: Medical Device
- Product Liability & Recall
- White Collar/Government Investigations
LMG Life Sciences also ranks King & Spalding as “recommended” in three other categories:
- FDA: Pharmaceutical
- Healthcare: Pricing & Reimbursement
- Licensing & Collaboration
In addition, LMG named 21 King & Spalding lawyers “Life Sciences Stars” in various practice areas.
The firm’s full rankings and analysis are available here.
LMG Life Sciences bases its research on online surveys and interviews with lawyers across the United States. Its researchers also speak to clients and leading lawyers within the industry and review public information to inform its decisions.
About King & Spalding
Celebrating more than 130 years of service, King & Spalding is an international law firm that represents a broad array of clients, including half of the Fortune Global 100, with 1,100 lawyers in 21 offices in the United States, Europe, the Middle East and Asia. The firm has handled matters in over 160 countries on six continents and is consistently recognized for the results it obtains, uncompromising commitment to quality, and dedication to understanding the business and culture of its clients. More information is available at www.kslaw.com.